Showing results (121-130 of 162) with videos related to
Sort By:
Pageof 17
Oncotarget|March 1, 2018
Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemiaQi Zhang, Ce Shi, Lina Han, et al.Blood|December 19, 2013
A targeted mutational landscape of angioimmunoblastic T-cell lymphomaOreofe Odejide, Oliver Weigert, Andrew A Lane, et al.Hemasphere|June 8, 2026
Access to diagnosis using liquid biopsy (ADLiB): Identifying lymphoma in a tuberculosis-endemic settingKatherine Antel, Nina Xiong, Mwanasha Merrill, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.Iscience|June 21, 2021
Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemiaBarry M Zee, Kamrine E Poels, Cong-Hui Yao, et al.Cell Reports|October 19, 2017
A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell LymphomasRussell J H Ryan, Jelena Petrovic, Dylan M Rausch, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemiaAkinori Yoda, Yuka Yoda, Sabina Chiaretti, et al.Cell Chemical Biology|June 8, 2023
New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutationMatthew L Arwood, Yao Liu, Shannon K Harkins, et al.Cancer Research|November 3, 2017
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft ModelsTerrence F Meehan, Nathalie Conte, Theodore Goldstein, et al.Science Advances|November 25, 2015
Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemiaAlexa S Green, Thiago T Maciel, Marie-Anne Hospital, et al.Pageof 17